Condition (MeSH)
Diurnal Enuresis
ClinicalTrials.gov lists 13 trials for Diurnal Enuresis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
13 of the 13 trials are tagged with Diurnal Enuresis itself; the rest are tagged with a narrower condition beneath it.
When did Diurnal Enuresis trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 3 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 1 |
| 2018 | 2 |
| 2017 | 1 |
| 2014 | 2 |
| 2013 | 1 |
No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Diurnal Enuresis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 6 |
| Observational | 4 |
How many Diurnal Enuresis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 4 |
| Withdrawn | 3 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| mirabegron OCAS | 1 |
| Solifenacin PO | 1 |
| Coloverin | 1 |
| BLOOD SAMPLE | 1 |
| Sham device | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Diurnal Enuresis? (14)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Prevalence of Urinary Incontinence and Its Association With Neurodevelopmental Disorders Among Children in Japan. | Neurourology and urodynamics | 2025 | Yes |
| Efficacy of Solifenacin, Mirabegron, and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry): Protocol for a Randomized Single-Blinded Controlled Trial. | JMIR research protocols | 2025 | Yes |
| Definitions, indications and practice of urotherapy in children and adolescents: - A standardization document of the International Children's Continence Society (ICCS). | Journal of pediatric urology | 2021 | Yes |
| Conservative interventions for treating functional daytime urinary incontinence in children. | The Cochrane database of systematic reviews | 2019 | Yes |
| Prevalence of nocturnal enuresis and related risk factors in school-age children in Egypt: an epidemiological study. | World journal of urology | 2017 | Yes |
Showing 5 of 14 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.